4
Changes in Ownership
SAB Biotherapeutics, Inc. Filed Acc 0001209191-22-031401
Director acquired 299,002 shares (other)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Spragens Jeffrey G Director | 2022-05-20 | Other acquisition | +299,002 | 312,002 | D |
Loading xslF345X03/doc4.xml…